2009
DOI: 10.3892/or_00000294
|View full text |Cite
|
Sign up to set email alerts
|

Expression of the prolyl isomerase Pin1 is a useful indicator of sensitivity to chemoradiotherapy in advanced esophageal squamous cell carcinoma

Abstract: Abstract. Cell cycle regulators, such as cyclinD1 and p53, play major roles in the tumor response to radiation and chemotherapy in esophageal squamous cell carcinoma (SCC). Pin1-mediated prolyl-isomerization potentiates cell cycle progression and cell proliferation, including the regulation of cyclinD1 and p53. Herein, we investigated the effect of Pin1 in association with cyclinD1 and p53 on the sensitivity of esophageal SCC to chemoradiotherapy (CRT). The expression levels of Pin1, cyclinD1 and p53 were exam… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
1

Year Published

2013
2013
2019
2019

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 29 publications
0
3
1
Order By: Relevance
“…Pin1 was expressed moderately or strongly in 56% ESCC tumors. The percentage of high Pin1 expression in our patients was higher than that of earlier reports, in which 31–37% of ESCC samples exhibited high Pin1 expression [ 9 11 ]. This difference might result from different IHC scoring criteria.…”
Section: Discussioncontrasting
confidence: 90%
See 2 more Smart Citations
“…Pin1 was expressed moderately or strongly in 56% ESCC tumors. The percentage of high Pin1 expression in our patients was higher than that of earlier reports, in which 31–37% of ESCC samples exhibited high Pin1 expression [ 9 11 ]. This difference might result from different IHC scoring criteria.…”
Section: Discussioncontrasting
confidence: 90%
“…The association between Pin1 expression and clinicopathlogical factors in ESCC was previously reported [ 9 11 ]. In this study, we examined Pin1 expression in ESCC specimens.…”
Section: Discussionmentioning
confidence: 72%
See 1 more Smart Citation
“…Concurrent chemotherapy consisted of 7 mg/m 2 docetaxel intravenously administered for 1 h before radiotherapy on days 1, 8, 15 and 22. Treatment, toxicity, and response evaluation details were previously described (26).…”
Section: Patients and Samplesmentioning
confidence: 99%